产后的抗生素暴露由于母体B型链球菌与儿童喘有关
Eyal Kristal1,2, Itamar Ben Shitrit1,3, Yoram Faitelson2
1Saban children's Hospital, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
概括
婴儿早期接触抗生素,即使没有感染,也会增加儿童喘风险. 这项研究强调了在评估喘发展时,需要考虑对孕产妇的抗生素使用.
科学领域:
- 儿科 儿科 儿科
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 早期的抗生素暴露是儿童喘的已知危险因素.
- 以前的研究可能会被抗生素使用的指示 (例如,呼吸道感染) 混.
- 这项研究旨在分离出母性原因给非感染婴儿的抗生素的作用.
研究的目的:
- 评估产后抗生素治疗对儿童喘风险的独特贡献.
- 为了减轻先前研究中婴儿感染的混偏差.
- 调查非传染性适用抗生素使用与喘发展之间的关联.
主要方法:
- 使用电子病历进行的回顾性队列研究 (2006-2018).
- 鉴定出患有阳性B组链球菌 (GBS) 培养的母亲出生的健康婴儿.
- 排除了有呼吸道症状或阳性培养的婴儿;用于分析的准森回归和倾向性得分匹配.
主要成果:
- 产后抗生素暴露与喘风险增加有关 (aRR=1.3,P=.017),通过倾向模型 (aRR=1.49,P=.005) 验证.
- 抗生素治疗也与短期β-agonist使用的增加有关 (aRR=1.13,P=.072) 和过敏性鼻炎诊断 (aRR=3.00,P=.003).
- 在控制混因子和排除感染的婴儿后,这种关联仍然存在.
结论:
- 产后抗生素治疗母亲的GBS,独立于婴儿感染,与更高的儿童喘风险有关.
- 研究结果表明,某些抗生素暴露对喘发展有直接影响.
- 强调了明智使用抗生素的重要性,即使对于孕产妇的指示.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management
593
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
593
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
461
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
461
Antiasthma Drugs: β2-Adrenoceptor Agonists
386
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
386


